الملخص
This research was conducted to study the physiological responses in purebred Arabian horses by knowing the biochemical changes in the level of Red Blood Cells and Hemoglobin before and after the 1600-meter race and knowing the effect of medicinal extracts of Ginseng, Phyllanthus, Saussurea Costus, Alpinia, Celery And Mustard Seeds, in addition to the vitamin B group and honey included in the Energy Fort preparation, in improving Physiological responses and alleviation of some of the effects of post-race muscle fatigue.
The horses were distributed into five groups, each group included six horses with similar weights according to the following:
-The First Group (G1): the normal control group. The horses were left without any race or exercise, to know the normal values of the studied variables (RBCs, Hb).
-The Second Group (G2): The horses underwent a 1,600-meter gallop, then blood samples were collected from them immediately after the race, as this group was considered a positive control for The Third Group.
-The Third Group (G3): The horses in this group were given an Energy Fort supplement at a dose of 2 ml / 100 kg of live weight immediately before the 1600-meter race, and then blood samples were collected from them immediately after the race.
-The Fourth Group (G4): The horses underwent a 1,600-meter gallop, then blood samples were collected from them immediately after the race, as this group was considered a positive control for The Fifth Group.
-The Fifth Group (G5): The horses in this group underwent a 1,600-meter gallop, then were given Energy Fort supplement at a dose of 2 ml/100 kg live weight immediately after the race, and half an hour after giving the supplement, blood samples were collected from this group.
All blood samples were obtained from the jugular vein.
The results showed that real changes occurred in the physiological responses, represented by a significant increase in the average concentrations of Red Blood Cells and Hemoglobin after the race in the positive control groups (G4-G2) when compared with the group of the normal control (G1), and a significant decrease in the average concentrations Red Blood Cells and Hemoglobin after the race in the groups Race (G5-G3) given Energy Fort supplement before and after race when compared with a positive control group (G2-G4)
References
2. Bain, S., Ramamurthy, N. S., Impeduglia, T., Scolman, S., Golub, L. M., & Rubin, C. (1997). Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone, 21(2), 147-153.
3. Bettany JT, Peet NM, Wolowacz RG, Skerry TM, Grabowski PS (2000) Tetracyclines induce apoptosis in osteoclasts. Bone 27: 75–80.
4. Bevelander, G., Nakahara, H., & Rolle, G. K. (1960). The effect of tetracycline on the development of the skeletal system of the chick embryo. Developmental biology, 2, 298–312.
5. Cheng, W., Yue, Y., Fan, W., Hu, Y., Wang, X., Pan, X., ... & Zhang, P. (2012). Effects of tetracyclines on bones: an ambiguous question needs to be clarified. Die Pharmazie-An International Journal of Pharmaceutical Sciences, 67(5), 457-459.
6. Cohlan, S. Q., Bevelander, G., & Tiamsic, T. (1963). Growth inhibition of prematures receiving tetracycline: a clinical and laboratory investigation of tetracycline-induced bone fluorescence. American Journal of Diseases of Children, 105(5), 453-461.
7. Czeizel, A. E., and Rockenbauer, M. (2000). A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy. European Journal of Obstetrics and Gynecology and Reproductive Biology, 88(1), 27-33.
8. Dashe, J. S., and Gilstrap III, L. C. (1997). Antibiotic use in pregnancy. Obstetrics and gynecology clinics of North America, 24(3), 617-629.
9. Donahue, H. J., Iijima, K., Goligorsky, M. S., Rubin, C. T., & Rifkin, B. R. (1992). Regulation of cytoplasmic calcium concentration in tetracycline‐treated osteoclasts. Journal of Bone and Mineral Research, 7(11), 1313-1318.
10. Duewelhenke, N., Krut, O., & Eysel, P. (2007). Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrobial agents and chemotherapy, 51(1), 54-63.
11. Faggion Jr, C. M. (2012). Guidelines for reporting pre-clinical in vitro studies on dental materials. Journal of Evidence Based Dental Practice, 12(4), 182-189.
12. Graur, D., Duret, L., and Gouy, M. (1996). Phylogenetic position of the order Lagomorpha (rabbits, hares and allies). Nature, 379(6563), 333-335.
13. Halme, J., & Aer, J. (1968). Effect of tetracycline on synthesis of collagen and incorporation of 45calcium into bone in foetal and pregnant rats. Biochemical Pharmacology, 17(8), 1479-1484.
14. Hautekeete, M. (1995). Hepatotoxicity of antibiotics. Acta gastro-enterologica Belgica, 58(3-4), 290-296.
15. Holmes SG, Still K, Buttle DJ, Bishop NJ, Grabowski PS (2004) Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors. Bone 35: 471–478.
16. Holmes, S. G., Still, K., Buttle, D. J., Bishop, N. J., & Grabowski, P. S. (2004). Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors. Bone, 35(2), 471-478.
17. Hughes, W. H., Lee, W. R., & Flood, D. J. (1965). A comparative study of the actions of six tetracyclines on the development of the chick embryo. British journal of pharmacology and chemotherapy, 25(2), 317–323.
18. Kaleelullah, R. A., and Garugula, N. (2021). Teratogenic Genesis in Fetal Malformations. Cureus, 13(2).
19. Kirkwood, K., Martin, T., Agnello, K., & Kim, Y. J. (2004). Differential regulation of MMP-13 by chemical modified tetracyclines in osteoblasts. Journal of the International Academy of Periodontology, 6(2), 39-46.
20. Laitinen O. (1967). The metabolism of collagen and its hormonal control in the rat with special emphasis on the interactions of collagen and calcium in the bones. Acta endocrinologica, 56, 1–86.
21. Likins, R. C., & Pakis, G. A. (1965). Foetal uptake of radiocalcium in tetracycline-treated rats. Nature, 207(5004), 1394–1395.
22. Linnett, P., & Dagg, P. (2005). The veterinary pharmacovigilance program of the APVMA. Australian veterinary journal, 83(1‐2), 32-37.
23. Miziara, I. D., Magalhães, A. T. d. M., Santos, M. d. A., Gomes, É. F., and Oliveira, R. A. d. (2012). Research ethics in animal models. Brazilian Journal of otorhinolaryngology, 78, 128-131.
24. Moore, K. (1988). The Developing Нuman. In: WB Saunders Philadelphia.
25. Niebyl, J. R. (2003). Antibiotics and other anti-infective agents in pregnancy and lactation. American journal of perinatology, 20(08), 405-414.
26. Paixão, R. L., and Schramm, F. R. (1999). Ethics and animal experimentation: what is debated? Cadernos de Saúde Pública, 15, S99-S110.
27. Philippart, P., Brasseur, M., Hoyaux, D., & Pochet, R. (2003). Human Recombinant Tissue Factor, Platelet-rich Plasma, and Tetracycline Induce a High-Quality Human Bone Graft: A 5-year Survey. International Journal of Oral & Maxillofacial Implants, 18(3).
28. Rall, D. P., Loo, T. L., Lane, M., & Kelly, M. G. (1957). Appearance and persistence of fluorescent material in tumor tissue after tetracycline administration. Journal of the National Cancer Institute, 19(1), 79-85.
29. Rall, D. P., Loo, T. L., Lane, M., & Kelly, M. G. (1957). Appearance and persistence of fluorescent material in tumor tissue after tetracycline administration. Journal of the National Cancer Institute, 19(1), 79-85.
30. Ramamurthy, N. S., Rifkin, B. R., Greenwald, R. A., Xu, J. W., Liu, Y., Turner, G., ... & Vernillo, A. T. (2002). Inhibition of matrix metalloproteinase‐mediated periodontal bone loss in rats: A comparison of 6 chemically modified tetracyclines. Journal of periodontology, 73(7), 726-734.
31. Riviere, J. E., & Papich, M. G. (Eds.). (2018). Veterinary pharmacology and therapeutics. John Wiley & Sons.
32. RJ, G., & TE, R. (1960). Transplacental transmission of demethylchlortetracycline and toxicity studies in premature and full term, newly born infants. Antibiotic Medicine & Clinical Therapy (New York, NY), 7, 618-622.
33. Sasaki, T., Kaneko, H., Ramamurthy, N. S., & Golub, L. M. (1991). Tetracycline administration restores osteoblast structure and function during experimental diabetes. The Anatomical Record, 231(1), 25-34.
34. Schimandle, J. H., and Boden, S. D. (1994). Spine update. The use of animal models to study spinal fusion. Spine, 19(17), 1998-2006.
35. Schlegel, P. N., Chang, T., and Marshall, F. F. (1991). Antibiotics: potential hazards to male fertility. Fertility and sterility, 55(2), 235-242.
36. Sternberg, J., Légaré, J. M., & Marcil, B. (1969). Kinetic studies with labeled bone-seekers in pregnant and lactating rats. The International Journal of Applied Radiation and Isotopes, 20(2), 81-95.